Intuitive Surgical, Inc. (ISRG)
| Market Cap | 199.67B |
| Revenue (ttm) | 8.71B |
| Net Income (ttm) | 2.48B |
| Shares Out | 358.42M |
| EPS (ttm) | 6.83 |
| PE Ratio | 81.56 |
| Forward PE | 68.69 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,103,092 |
| Open | 562.18 |
| Previous Close | 558.06 |
| Day's Range | 555.76 - 564.15 |
| 52-Week Range | 405.08 - 616.00 |
| Beta | 1.68 |
| Analysts | Strong Buy |
| Price Target | 592.44 (+6.35%) |
| Earnings Date | Jul 17, 2025 |
About ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling,... [Read more]
Financial Performance
In 2024, Intuitive Surgical's revenue was $8.35 billion, an increase of 17.24% compared to the previous year's $7.12 billion. Earnings were $2.32 billion, an increase of 29.18%.
Financial StatementsAnalyst Forecast
According to 17 analysts, the average rating for ISRG stock is "Strong Buy." The 12-month stock price forecast is $592.44, which is an increase of 6.35% from the latest price.
News
Trade Tracker: Stephanie Link sells Nextera and buys more Intuitive Surgical
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest portfolio moves.
AVGO Beat and Raise? Plus, Demmert's Stock Picks: ISRG, BYDDY
James Demmert drops by the NYSE set with a couple of stocks to watch: Intuitive Surgical (ISRG) and BYD (BYDDY). He says both are plays that avoid a potential U.S. slowdown.
How pet medicine stocks could cushion your healthcare investments from Trump changes
Moderna shares are seeing a boost on Monday after the US Food and Drug Administration (FDA) gave the pharmaceutical giant limited approval for its lower-dose COVID-19 vaccine. Morgan Stanley Investmen...
Intuitive Surgical: More Than Robots - Why Its AI-Powered Platform Deserves A Premium
Intuitive Surgical's deep R&D investment and da Vinci 5 platform create a powerful innovation moat and embed the company further into surgical workflows. Recurring revenue from a growing installed bas...
Intuitive Surgical: Moat, Resilience But High Market Expectations
Intuitive Surgical remains a dominant leader in robotic surgery with strong recurring revenues, high switching costs, and robust financial health. Business fundamentals are excellent, with resilient p...
Intuitive Surgical: The Business Model Of Robotic Surgery Supports A Bullish Outlook
Intuitive Surgical's share price has rebounded after a sharp drop, driven by strong Q1 2025 results and easing tariff concerns, with further upside expected. As the dominant leader in robotic surgery,...
Intuitive Announces CEO Transition Effective July 1, 2025
President Dave Rosa promoted to CEO Current CEO Gary Guthart to become executive chair of Intuitive's board Current Board Chair Craig Barratt to become lead independent director
Trade Tracker: Stephanie Link sells Eli Lilly and buys more Intuitive Surgical
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest portfolio moves.
Stock Picks From Seeking Alpha's April 2025 New Analysts
In April, Seeking Alpha welcomed 20 new analysts. This article introduces them and showcases some of their top picks. Top picks include Palantir, Arch Capital Group, and Utah Medical Products, emphasi...
Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection
SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that th...
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopha...
Baron Health Care Fund Q1 2025 Top Contributors And Detractors
Boston Scientific's shares rose due to strong market growth, innovative products like pulsed field ablation, and disciplined cost management, driving double-digit EPS growth. Vertex Pharmaceuticals sa...
Trade Tracker: Stephanie Link buys Intuitive Surgical
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest buy of Intuitive Surgical
Intuitive Surgical: Decent Results But Waiting For An Entry Point
Intuitive Surgical's Q1 2025 earnings showed mixed results, with revenue and EPS beating expectations, but gross margins impacted by tariffs and a lower-margin product mix. Procedure volume growth was...
Analysts Remain Bullish On Intuitive Surgical Despite Macro Uncertainty
Intuitive Surgical Inc ISRG reported first-quarter 2025 revenue of $2.25 billion, beating analyst estimates of $2.19 billion.
These Analysts Lower Their Forecasts On Intuitive Surgical After Q1 Earnings
Intuitive Surgical Inc ISRG reported better-than-expected first-quarter financial results Tuesday after the bell.
Intuitive Surgical Stock Is Surging. Tariffs Could Be Less of a Threat.
Surgical robots firm Intuitive Surgical said exports to and imports from China are subject to high tariffs. Shares are rising Wednesday on hopes the trade war will de-escalate.
Intuitive Surgical, Inc. (ISRG) Q1 2025 Earnings Call Transcript
Intuitive Surgical, Inc. (NASDAQ:ISRG) Q1 2025 Earnings Conference Call April 22, 2025 4:30 AM ET Company Participants Dan Connally - Head of IR Gary Guthart - CEO David Rosa - President Jamie Samath...
Intuitive Surgical beats quarterly results, raises tariff concerns
Intuitive Surgical raised concerns on Tuesday about the potential impact of tariffs on its annual results, despite exceeding Wall Street's first-quarter profit and revenue estimates.
Intuitive Announces First Quarter Earnings
SUNNYVALE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today...
Final Trades: 3M, Abbvie, Salesforce and Intuitive Surgical
The Investment Committee give you their top stocks to watch for the second half.
Intuitive Surgical Braces For Q1 Check-Up As Bears Crowd The Operating Room
Intuitive Surgical Inc ISRG will report its first-quarter earnings after the market closes on Tuesday. Wall Street expects earnings per share of $1.72 and revenue of $2.19 billion for the quarter.
New Research Explores Access to Minimally Invasive Care and the Impact of Robotic-Assisted Surgery
Studies show robotic-assisted procedures enable increased access to minimally invasive care Studies show robotic-assisted procedures enable increased access to minimally invasive care
U.S. FDA clears first stapler designed for single-port robotic surgery
Intuitive's SureForm 45 stapler available for thoracic, colorectal, and urology procedures Intuitive's SureForm 45 stapler available for thoracic, colorectal, and urology procedures